Malnourished paediatric cystic fibrosis patients show significant weight gain and improved pulmonary function after short-term therapy with megestrol acetate.
Patients prescribed megestrol reached 100 percent of their ideal body weight within three months of therapy initiation. Their weight gain included both fat and fat-free mass, researchers from the University of Alabama at Birmingham and the University of Florida at Gainesville report.
Malnutrition is a negative prognostic indicator in cystic fibrosis patients and can also accentuate pulmonary decline. Investigators tested whether megestrol would benefit growth in 17 patients with cystic fibrosis and pancreatic insufficiency.
Participants were all taking replacement enzymes to compensate for the pancreatic insufficiency. The children were randomly assigned to megestrol or placebo in a double-blind study.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!